In recent days, BMO Capital highlighted Chemours’ sale of its Taiwan titanium dioxide site for US$360,000,000 as a key balance-sheet event, with proceeds expected to be used for debt reduction and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results